RECURRENT LUNG NON-SMALL CELL CARCINOMA
Clinical trials for RECURRENT LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Proton beam therapy doses tested for inoperable lung cancer
Disease control CompletedThis study looked at 20 adults with stage 2-3 non-small cell lung cancer that could not be removed by surgery. Participants received standard chemotherapy along with different doses of proton beam therapy to find the safest and most effective dose. The goal was to improve cancer …
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New cocktail of immune drugs shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) plus a targeted therapy (selumetinib) in 40 adults with advanced non-small cell lung cancer that had returned or spread. The goal was to find the best dose and see if the combo could shrink t…
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
New combo therapy targets Drug-Resistant lung cancer
Disease control CompletedThis early-phase trial tested two experimental drug combinations (osimertinib plus alisertib or sapanisertib) in 37 adults with advanced EGFR-mutant non-small cell lung cancer that no longer responded to osimertinib alone. The main goals were to find the safest dose and check for…
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC